MFDS announces change order, temporarily wrapping up the ‘olmesartan’ issue
The Ministry of Food and Drug Safety(MFDS) held the Central Pharmacists Deliberation Committee, and announced the change order of the olmesartan’s approval after reviewing its relevant safety information.
According to the change order, the MFDS added an article stating ‘It cannot be re-administ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
